COVID-19 through Adverse Outcome Pathways: Building networks to better understand the disease - 3rd CIAO AOP Design Workshop.


Journal

ALTEX
ISSN: 1868-8551
Titre abrégé: ALTEX
Pays: Germany
ID NLM: 100953980

Informations de publication

Date de publication:
2022
Historique:
received: 16 12 2021
accepted: 17 12 2021
entrez: 15 1 2022
pubmed: 16 1 2022
medline: 15 4 2022
Statut: ppublish

Résumé

On April 28-29, 2021, 50 scientists from different fields of expertise met for the 3rd online CIAO workshop. The CIAO project “Modelling the Pathogenesis of COVID-19 using the Adverse Outcome Pathway (AOP) framework” aims at building a holistic assembly of the available scientific knowledge on COVID-19 using the AOP framework. An individual AOP depicts the disease progression from the initial contact with the SARS-CoV-2 virus through biological key events (KE) toward an adverse outcome such as respiratory distress, anosmia or multiorgan failure. Assembling the individual AOPs into a network highlights shared KEs as central biological nodes involved in multiple outcomes observed in COVID-19 patients. During the workshop, the KEs and AOPs established so far by the CIAO members were presented and posi­tioned on a timeline of the disease course. Modulating factors influencing the progression and severity of the disease were also addressed as well as factors beyond purely biological phenomena. CIAO relies on an interdisciplinary crowd­sourcing effort, therefore, approaches to expand the CIAO network by widening the crowd and reaching stakeholders were also discussed. To conclude the workshop, it was decided that the AOPs/KEs will be further consolidated, inte­grating virus variants and long COVID when relevant, while an outreach campaign will be launched to broaden the CIAO scientific crowd.

Identifiants

pubmed: 35032963
doi: 10.14573/altex.2112161
pmc: PMC10069302
mid: NIHMS1867515
doi:

Types de publication

Editorial

Langues

eng

Sous-ensembles de citation

IM

Pagination

322–335

Subventions

Organisme : Intramural EPA
ID : EPA999999
Pays : United States

Références

Toxicol Sci. 2018 Jun 1;163(2):346-352
pubmed: 29850905
BMJ Open. 2020 Aug 5;10(8):e039856
pubmed: 32759252
Clin Epidemiol Glob Health. 2021 Jan-Mar;9:157-161
pubmed: 32869006
Front Pharmacol. 2021 Jan 15;11:601685
pubmed: 33519463
J Transl Med. 2020 Jul 3;18(1):270
pubmed: 32620125
Toxicol Sci. 2014 Dec;142(2):312-20
pubmed: 25466378
Front Public Health. 2021 May 19;9:638605
pubmed: 34095051
ALTEX. 2021 Mar 05;38(2):351-357
pubmed: 33677612
Mod Pathol. 2020 Nov;33(11):2128-2138
pubmed: 32572155
Nano Today. 2020 Dec;35:100945
pubmed: 32834832
Toxicology. 2013 Oct 4;312:158-65
pubmed: 23978457
JAMA. 2020 Dec 8;324(22):2251-2252
pubmed: 33206133

Auteurs

Laure-Alix Clerbaux (LA)

European Commission, Joint Research Centre, Ispra, Italy.

Núria Amigó (N)

Biosfer Teslab, Reus, Spain.

Maria João Amorim (MJ)

Instituto Gulbenkian de Ciência, Lisbon, Portugal.

Anna Bal-Price (A)

European Commission, Joint Research Centre, Ispra, Italy.

Sofia Batista Leite (S)

European Commission, Joint Research Centre, Ispra, Italy.

Anna Beronius (A)

Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

Gillina F G Bezemer (GFG)

Impact Station, Hilversum, The Netherlands.

Ann-Charlotte Bostroem (AC)

European Commission, Joint Research Centre, Ispra, Italy.

Annamaria Carusi (A)

Interchange Research, London, UK.

Sandra Coecke (S)

European Commission, Joint Research Centre, Ispra, Italy.

Rachel Concha (R)

Fairleigh Dickinson University, Green Neuroscience Laboratory, San Diego, CA, USA

Evangelos P Daskalopoulos (EP)

European Commission, Joint Research Centre, Ispra, Italy.

Francesca De Bernardi (F)

Division of Otorhinolaryngology, Department of Biotechnologies and Life Sciences, University of Insubria, Ospedale di Circolo e Fondazione Macchi, Varese, Italy.

Eizleayne Edrosa (E)

Green Neuroscience Laboratory, Neurolinx Research Institute, San Diego, CA, USA

Steve W Edwards (SW)

RTI International, Research Triangle Park, NC, USA.

Julija Filipovska (J)

Independent scientist, Ohrid, North Macedonia.

Natàlia Garcia-Reyero (N)

US Army Engineer Research and Development Center, Vicksburg, MS, USA.

Felicity N E Gavins (FNE)

The Centre for Inflammation Research and Translational Medicine (CIRTM), Brunel University London, London, UK.

Sabina Halappanavar (S)

Environmental Health Science and Research Bureau, Health Canada, Ottawa, Ontario, Canada.

Alan J Hargreaves (AJ)

School of Science and Technology, Nottingham Trent University, Nottingham, UK.

Helena T Hogberg (HT)

Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Mylène T Huynh (MT)

Department of Preventive Medicine and Biometrics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.

Daniel Jacobson (D)

Biosciences, Oak Ridge National Laboratory, Oak Ridge, TN, USA.

Jonathan Josephs-Spaulding (J)

Institute for Experimental Medicine, Kiel University, Kiel, Germany.

Young Jun Kim (YJ)

Korea Institute of Science and Technology Europe Forschungsgesellschaft mbH, Saarbrücken, Germany.

Hyun Joon Kong (HJ)

University of Illinois at Urbana-Champaign, Champaign, IL, USA.

Catharine E Krebs (CE)

Physicians Committee for Responsible Medicine, Washington, DC, USA.

Ann Lam (A)

Green Neuroscience Laboratory, Neurolinx Research Institute, San Diego, CA, USA

Brigitte Landesmann (B)

European Commission, Joint Research Centre, Ispra, Italy.

Adrienne Layton (A)

US Consumer Product Safety Commission, Bethesda, MD, USA.

Yong Oh Lee (YO)

Korea Institute of Science and Technology Europe Forschungsgesellschaft mbH, Saarbrücken, Germany.

Donna S Macmillan (DS)

Humane Society International, Washington, DC, USA.

Alberto Mantovani (A)

Istituto Superiore di Sanità, Rome, Italy.

Luigi Margiotta-Casaluci (L)

The Centre for Inflammation Research and Translational Medicine (CIRTM), Brunel University London, London, UK.

Marvin Martens (M)

Department of Bioinformatics - BiGCaT, NUTRIM, Maastricht University, Maastricht, The Netherlands.

Rosalinde Masereeuw (R)

Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.

Sally A Mayasich (SA)

University of Wisconsin-Madison Aquatic Sciences Center at US EPA, Duluth, MN, USA.

Liang Merlin Mei (LM)

US EPA, Durham, NC, USA.

Holly Mortensen (H)

US EPA, Durham, NC, USA.

Amalia Munoz Pineiro (A)

European Commission, Joint Research Centre, Geel, Belgium.

Penny Nymark (P)

Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

Elan Ohayon (E)

Green Neuroscience Laboratory, Neurolinx Research Institute, San Diego, CA, USA

Joshi Ojasi (J)

Hiranandani College of Pharmacy, Mumbai, India.

Alicia Paini (A)

European Commission, Joint Research Centre, Ispra, Italy.

Nikolaos Parissis (N)

European Commission, Joint Research Centre, Ispra, Italy.

Surat Parvatam (S)

Centre for Predictive Human Model Systems Atal Incubation Centre - Centre for Cellular and Molecular Biology Habsiguda, Hyderabad, India.

Francesca Pistollato (F)

European Commission, Joint Research Centre, Ispra, Italy. Francesca.PISTOLLATO@ec.europa.eu.

Magdalini Sachana (M)

Environment Health and Safety Division, Environment Directorate, Organisation for Economic Cooperation and Development (OECD), Paris, France.

Jorid Birkelund Sørli (JB)

The National Research Centre for the Working Environment, Copenhagen, Denmark.

Kristie M Sullivan (KM)

Physicians Committee for Responsible Medicine, Washington, DC, USA.

Jukka Sund (J)

European Commission, Joint Research Centre, Ispra, Italy.

Shihori Tanabe (S)

Division of Risk Assessment, Center for Biological Safety and Research, National Institute of Health Sciences, Kawasaki, Japan.

Katya Tsaioun (K)

Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Mathieu Vinken (M)

Department of Pharmaceutical and Pharmacological Sciences, Vrije Universiteit Brussel, Brussels, Belgium.

Laura Viviani (L)

Humane Society International, Washington, DC, USA.

Jennifer Waspe (J)

Sheffield Teaching Hospitals, Sheffield, UK.

Catherine Willett (C)

Humane Society International, Washington, DC, USA.

Clemens Wittwehr (C)

European Commission, Joint Research Centre, Ispra, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH